Skip to main content

Epilepsy Clinical Trials in Illinois and Michigan

Struggling to Manage Seizures with Traditional Treatments?

Explore Epilepsy Clinical Trials in Rochester Hills, Michigan Investigating Novel Treatment Options

Epilepsy is a neurological condition associated with unprovoked seizures along with abnormal activity in the brain. These are sudden, temporary disturbances in brain function that can cause a wide range of symptoms including convulsions, altered consciousness, and unusual sensations. Seizures can vary in frequency, duration, and severity from person to person.

Revive Research Institute is conducting epilepsy clinical research studies in Rochester Hills, Michigan investigating novel treatments that may be able to help you and countless others manage symptoms of epilepsy.

You may qualify for the paid Epilepsy Clinical Study near you if you are:

  • Male or female, aged 18 to 75 years
  • Diagnosed with Focal Onset Epilepsy at least 1 year prior

*Additional criteria may apply

*Take part in paid Epilepsy Clinical Trials at no cost to you or your medical insurance. You will be reimbursed financially for your time and travel. In addition, all participants receive study-related care from an experienced research team.

*If you are interested in participating in the Epilepsy Clinical Trials or would like more information, please fill out the form so we can determine if you qualify for the study and contact you. Note that this is an entirely voluntary decision.

Please provide YOUR contact information only.
For more info, please visit Privacy Policy.

About Epilepsy Clinical Trials

Epilepsy, a neurological condition affecting millions worldwide, requires ongoing research to develop effective treatments. We are currently conducting Epilepsy Clinical Trials in Rochester Hills Michigan, aiming to evaluate the safety and efficacy of an investigational medication in adult males and females (age 18 to 75) with epilepsy-related symptoms. With over 3.4 million Americans living with epilepsy, your participation can contribute to groundbreaking advancements in epilepsy care.

The Epilepsy Clinical Study’s treatment phase for participants will last for 24 weeks. To ensure study eligibility, all participants must comply with all study procedures. Participants who meet the eligibility criteria after undergoing an 8-week observation phase and are chosen to participate will be given 12 weeks of double-blind active treatment. We’re looking into the safety and efficacy of an oral investigational drug used to treat uncontrollable seizures in epilepsy.

*There is no cost to you, your private medical insurance, or the public health insurance plan for study procedures. The study drug, related procedures, and visits will be provided at no charge for the duration of the Focal Epilepsy Clinical Study.

Get Started: What to Expect?

If you are struggling with focal onset epilepsy or unprovoked seizures, this study may be for you. This is a phase II/III study evaluating the safety and efficacy of an investigational medication in adults who are no longer responding to traditional treatment.

After completing the online form above, one of the members from the research team will contact you to determine whether you are a good fit for the Focal Epilepsy Clinical Trial currently underway. After your eligibility is confirmed, you will be asked to sign an Informed Consent Form (ICF). This will take place during a screening/introductory Visit, for which you will be requested to visit the clinical site. Following your signature, you will be asked a series of questions about your health and medical history, as well as subjected to a few tests to make sure that you fulfill the eligibility criteria of the study.

If you fulfill the criteria and decide to participate in the Epilepsy Research Studies, the study will last for approximately 22 weeks. You will be given the study drug or a placebo, which must be taken orally, during this time. The placebo is a drug without active ingredients. Neither you nor your study doctor will know which drug you receive.

*All study-related care is provided free of cost. Complete physical examination and other study-related assessments will be done by expert physicians and health care experts.

Length of study Treatment

24 weeks

Number of study visits

7 visits

Location

Illinois and Michigan

About Focal Epilepsy

Epilepsy is a neurological disease associated with unprovoked seizures along with abnormal activity in the brain. Focal onset epilepsy, also known as partial epilepsy, is a syndrome of unprovoked seizures impacting about 1.2% of the adult population making it the most common neurological condition.

There are two types:

Focal Onset Impaired Awareness Seizure

During a focal onset impaired awareness seizure, you may lose consciousness. It may last a minute or two, and you may have warning signs such as unease or nausea before the seizure. You may feel tired and confused after the seizure.

Focal Onset Aware Seizures

A focal onset aware seizure will not cause you to lose consciousness and will last for a minute or less.

Symptoms of a Focal Seizure:

  • Muscle contractions, followed by relaxation
  • Unusual head or eye movements
  • Sensation of numbness, tingling
  • Abdominal pain
  • Rapid increase in heart rate or pulse
  • Sweating
  • Nausea
  • Flushed face
  • Dilated pupils or vision changes
  • Mood changes
  • Blackouts

Frequently Asked Questions (FAQs)

1. How common is Focal Epilepsy?

Focal seizures are the most common type of seizures in people with epilepsy.

2. Who is affected by Focal Epilepsy?

Focal epileptic seizures are most common in people who have had a head injury, birth abnormalities of their brain, febrile seizures as a kid, infections of their brain (encephalitis), strokes, brain tumors, or other disorders that affect their brain. It affects both men and women.

3. What is focal epilepsy treatment?

For seizures of all kinds, the most common treatment is medication. People may be able to recover from seizures with correct assistance and personalized treatment. Treatment usually involves some anticonvulsant medications.

4. Will my medical information be kept private?

Your personal health information will be handled in a private manner by the research doctor and study staff. All your personal and health-related information will be kept private under the privacy rule of HIPAA.

5. How do I know if I am eligible to be a part of the Focal Epilepsy Clinical Trials?

Every clinical trial has a strict criterion of who should be included or excluded from the study. Your age, gender, the type and stage of your disease, previous treatment history, and other medical conditions are some of the points of eligibility criteria. If you would like to participate in the epilepsy clinical research studies in Michigan, please have a look at the eligibility criteria above and fill out the form.

Close Menu

Revive Research Institute, Inc.

28270 Franklin Road
Southfield, MI
48034

T: 248-564-1485
E: info@rev-research.com